Ljubljana, Slovenia

Gregor Anderluh

This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Newcastle University Ventures Limited. Active years: 2008.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Gregor Anderluh. Retrieved from https://idiyas.com/inventor/gregor-anderluh

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2008

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Gregor Anderluh

Introduction

Gregor Anderluh is a notable inventor based in Ljubljana, Slovenia. He has made significant contributions to the field of biotechnology, particularly through his work on fusion proteins. His innovative approach has led to advancements in expression and purification systems, showcasing his expertise in the area.

Latest Patents

Gregor Anderluh holds a patent related to fusion proteins. The invention focuses on fusion polypeptides, specifically designed for use in expression and purification systems. The TolAIII domain, identified by Anderluh, exhibits remarkable properties that enhance expression levels in host cells. In his patent, a TolAIII domain or its functional homologues, fragments, or derivatives are positioned towards the N-terminus of the fusion polypeptide, while a non-TolA polypeptide is located at the C-terminus.

Career Highlights

Throughout his career, Gregor Anderluh has worked with various esteemed organizations. Notably, he has been associated with Newcastle University Ventures Limited and the Kemijski Institut. His work in these institutions has allowed him to further his research and development in the field of biotechnology.

Collaborations

Some of his notable coworkers include Isa Gokce and Jeremy Hugh Lakey. Their collaborative efforts have contributed to the advancements in the research and applications of fusion proteins.

Conclusion

Gregor Anderluh's contributions to the field of biotechnology, particularly through his patent on fusion proteins, highlight his innovative spirit and dedication to scientific advancement. His work continues to influence the development of effective expression and purification systems.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…